Clinical Trial Update: Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years [Phase 3]

View source ↗

Summary

Phase 3 randomized trial in young children with cystic fibrosis evaluating treatment of early Pseudomonas aeruginosa lung infections; the study completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Treatment of Early Pulmonary Infections With P. Aeruginosa in Cystic Fibrosis Patients | Phase 3 | Status: COMPLETED | Results posted: 2016-04-27